Viatris Inc

VTRS

Equity

ISIN US92556V1061 / Valor 58198423

NASDAQ (2024-09-18)

USD 11.90+0.68%

Viatris Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Viatris Inc is a global healthcare company that specializes in providing a wide range of quality medications across various therapeutic areas. The company is dedicated to expanding access to these medications for people around the world, regardless of their location or situation. Viatris aims to empower individuals by ensuring they have access to trusted healthcare solutions.

Summarized from source with an LLMView SourceSector: Healthcare

Total Revenues

Viatris Inc. reported total revenues of $15.4 billion for the fourth quarter and full year 2023. This figure aligns with the company's guidance range provided earlier in the year, demonstrating strong performance and operational stability.

Net Earnings

For the fourth quarter and full year 2023, Viatris Inc. achieved U.S. GAAP net earnings of $54.7 million. This positive result reflects the company's ability to manage its operations effectively and generate profit despite market challenges.

Adjusted EBITDA

Viatris Inc. reported an adjusted EBITDA of $5.1 billion for the fourth quarter and full year 2023. This metric is crucial as it indicates the company's earnings before interest, taxes, depreciation, and amortization, showcasing its operational efficiency.

Free Cash Flow

In 2023, Viatris Inc. generated a free cash flow of $2.4 billion. This strong cash flow performance underscores the company's ability to generate cash from its operations, which is vital for funding future growth and returning capital to shareholders.

Dividend Policy

Viatris Inc.'s Board of Directors has maintained a dividend policy for 2024 of 48 cents ($0.48) per share and declared a first-quarter dividend of 12 cents ($0.12) per share. This decision reflects the company's commitment to returning value to its shareholders.

Summarized from source with an LLMView Source

Key figures

21.2%1Y

-12.3%3Y

-44.1%5Y

Performance

27.4%1Y

33.6%3Y

36.8%5Y

Volatility